Cargando…

Using machine learning to uncover heterogeneity of beta blocker response in heart failure

A recent study by Karwath et al.(1) in The Lancet applied machine learning-based cluster analysis to pooled data from nine double-blind, randomized controlled trials of beta blockers, identifying subgroups of efficacy in patients with sinus rhythm and atrial fibrillation.

Detalles Bibliográficos
Autor principal: Tison, Geoffrey H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784765/
https://www.ncbi.nlm.nih.gov/pubmed/35106513
http://dx.doi.org/10.1016/j.xcrm.2021.100504